Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Will Exceed $10 Billion by 2021
The Type 2 Diabetes Mellitus (T2DM) market is expected to grow from $6.07 billion in 2014, to $10.2 billion in 2021, at a CAGR of 7.7%. This growth will be driven by the rapidly expanding prevalence population, due to increasingly aging populations and sedentary lifestyles, as well as increases in the diagnosis and treatment rates, due to rising disease awareness among the public. The increased uptake of recently approved and emerging branded therapeutics, in favour of lower-cost generic products, will...
View full press release